Both Relypsa Inc (NASDAQ:RLYP) and Intercept Pharmaceuticals Inc (NASDAQ:ICPT) received welcome news recently as a competing drug to Relypsa’s Veltassa encounters some difficulties …
Oppenheimer analysts are out with research notes on drug makers Relypsa Inc (NASDAQ:RLYP) and Opko Health Inc. (NYSE:OPK).
As Valeant Pharmaceuticals Intl Inc (NYSE:VRX) continues to face legal battles on several fronts and Relypsa Inc (NASDAQ:RLYP) struggles to ramp sales of …
Valeant Pharmaceuticals Intl Inc Shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) are up over 7% today after the Wall Street Journal reported Friday that Valeant recently rejected a …
Healthcare analysts weigh in today on Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) and Relypsa Inc (NASDAQ:RLYP), as shares of both pharma companies took off following FDA announcements.
Relypsa Inc (NASDAQ:RLYP), a biopharmaceutical company, today announced that the company has submitted a supplemental New Drug Application (sNDA) to the U.S.
Relpysa Inc (NASDAQ:RLYP) is up over 5% after positive data from its hyperkalemia treatment, Veltassa. The company released data from analyses of studies …
Relypsa Inc In a research report issued today, Wedbush analyst Liana Moussatos weighed in on drug maker Relypsa Inc (NASDAQ:RLYP), after the company released Veltassa (patiromer) …
Relypsa Inc (NASDAQ:RLYP), a biopharmaceutical company, reported financial results for the quarter ended March 31, 2016. Total revenues for the first quarter 2016 were …
Glu Mobile Inc. (NASDAQ:GLUU) is falling over 14% in pre-market trading after the company released Q1:16 earnings yesterday after market close.
